Principles and clinical application of assessing alterations in renal elimination pathways.
about
A survey of renal impairment pharmacokinetic studies for new oncology drug approvals in the USA from 2010 to early 2015: a focus on development strategies and future directionsPostnatal Maturation of the Glomerular Filtration Rate in Conventional Growing Piglets As Potential Juvenile Animal Model for Preclinical Pharmaceutical ResearchDetermining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds.Renal function, bisphenol A, and alkylphenols: results from the National Health and Nutrition Examination Survey (NHANES 2003-2006)Glomerular filtration rate (GFR) determination via individual kinetics of the inulin-like polyfructosan sinistrin versus creatinine-based population-derived regression formulae.Pharmacokinetics of p-Aminohippuric Acid and Inulin in Rabbits with Aristolochic Acid NephropathyNull mutation of the nicotinamide adenine dinucleotide phosphate-oxidase subunit p67phox protects the Dahl-S rat from salt-induced reductions in medullary blood flow and glomerular filtration ratePopulation pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using Monte Carlo simulations to predict doses for specified pharmacodynamic targets.Influence of morbid obesity on the single-dose pharmacokinetics of daptomycin.Anti-factor Xa activity of enoxaparin administered at prophylactic dosage to patients over 75 years oldEffect of impaired renal function on the pharmacokinetics of tomopenem (RO4908463/CS-023), a novel carbapenemAppropriateness of drug dose and frequency in patients with renal dysfunction in a tertiary care hospital: A cross-sectional studyMedications in the kidney.Progression of glomerular filtration rate reduction determined in conscious Dahl salt-sensitive hypertensive rats.Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state.Monitoring renal function: measured and estimated glomerular filtration rates - a review.Clearance and beyond: the complementary roles of GFR measurement and injury biomarkers in acute kidney injury (AKI).Is antiarrhythmic treatment in the elderly different? a review of the specific changes.Does Secretory Clearance Follow Glomerular Filtration Rate in Chronic Kidney Diseases? Reconsidering the Intact Nephron Hypothesis.Organic anion transporter OAT1 is involved in renal handling of citrulline.Effect of dronedarone on renal function in healthy subjects.
P2860
Q30491777-82FC39FE-9727-4E72-9CD6-DF780946AD77Q33849614-FE994105-0985-4C1F-842B-7D0C90E747CDQ34739945-285BCCE3-1503-49BD-8C4B-1859814E655CQ34834681-6BCEEA5B-132A-4FEF-AC87-76AB09D88CDDQ34856938-9749807A-0E74-4E1A-86A9-9596E44C9892Q35070926-CEBDB985-9AD1-41AF-ADBE-A4FF733C2B62Q35079456-69543A0C-8082-4020-B2E2-011395BFA0CEQ35598414-11E67C08-586F-47C0-BDF5-9969DAC39E15Q35912780-09F7F3CC-1848-47D5-A207-DEAB61C1B195Q36102602-425089D5-77E2-47D6-84AE-3E174278B48AQ36744822-FA60FD28-0D53-4A92-9D46-6FA06A82BBD5Q36969326-9BDAABD2-13CD-4A31-901A-D30FCBEF4C71Q37198832-213CDF10-5426-465A-9D10-C064F0EB2A20Q37251235-6B34C4AE-4FD4-4EFD-BBA3-30456527F7DFQ37740151-DB0EA763-A6E0-423D-BA02-2CEFB8694E08Q37750515-BDF2B3A5-0844-4010-B816-F302BF15003EQ37900798-5C897CAD-260C-4763-9A83-B5D1FEE36736Q37910895-616C9CBC-2217-42CA-AC78-05606F5E24B6Q38694525-D837AE99-AE3C-4A95-A2DA-646BD1C429C0Q39858796-1EACF676-5517-447D-B182-86172AAFE46FQ42951307-CC84DC4D-EFE5-4E88-8D87-AC6A3FCA995A
P2860
Principles and clinical application of assessing alterations in renal elimination pathways.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Principles and clinical applic ...... in renal elimination pathways.
@ast
Principles and clinical applic ...... in renal elimination pathways.
@en
type
label
Principles and clinical applic ...... in renal elimination pathways.
@ast
Principles and clinical applic ...... in renal elimination pathways.
@en
prefLabel
Principles and clinical applic ...... in renal elimination pathways.
@ast
Principles and clinical applic ...... in renal elimination pathways.
@en
P1476
Principles and clinical applic ...... in renal elimination pathways
@en
P2093
Annette S Gross
Susan E Tett
P304
P356
10.2165/00003088-200342140-00002
P577
2003-01-01T00:00:00Z
P5875
P6179
1027252871